TPST: Tempest Therapeutics, Inc. Stock

by  •  • Comments Off on TPST: Tempest Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 23.44
Enterprise Value ($M) 6.12
Book Value ($M) 11.13
Book Value / Share 3.18
Price / Book 2.11
NCAV ($M) 1.40
NCAV / Share 0.40
Price / NCAV 16.72

Profitability (mra)
Return on Invested Capital (ROIC) -1.85
Return on Assets (ROA) -1.01
Return on Equity (ROE) -2.17

Liquidity (mrq)
Quick Ratio 1.70
Current Ratio 1.70

Balance Sheet (mrq) ($M)
Current Assets 22.43
Assets 32.16
Liabilities 21.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -42.03
Net Income -41.84
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -33.03
Cash from Investing -0.43
Cash from Financing 24.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-11 13D/A Versant Venture Capital VI, L.P. 4.80 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-04-30 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRA
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-20 7,083 31,734 22.32
2025-05-19 3,271 28,224 11.59
2025-05-16 46,765 115,828 40.37
2025-05-15 9,181 39,453 23.27

(click for more detail)

Similar Companies
TLSA – Tiziana Life Sciences Ltd TNFA – TNF Pharmaceuticals, Inc.
TNXP – Tonix Pharmaceuticals Holding Corp. TRAW – Traws Pharma, Inc.
TSBX – Turnstone Biologics Corp.


Financial data and stock pages provided by
Fintel.io